I10E

DRUG2 trials

Sponsors

Laboratoire français de Fractionnement et de Biotechnologies

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Phase 3

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP

CompletedNCT02293460

Laboratoire français de Fractionnement et de BiotechnologiesChronic Inflammatory Demyelinating Polyradiculoneuropathy

Start: 2015-05-31End: 2017-09-29Updated: 2021-01-27

Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302

TerminatedNCT02317562

Laboratoire français de Fractionnement et de BiotechnologiesChronic Inflammatory Demyelinating Polyradiculoneuropathy

Start: 2015-11-30End: 2017-07-28Updated: 2021-04-20